# Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat

> **NCT07004010** · NA · COMPLETED · sponsor: **Espad Pharmed** · enrollment: 30 (actual)

## Conditions studied

- Flank Fat

## Interventions

- **DEVICE:** Deoxycholic Acid Injection

## Key facts

- **NCT ID:** NCT07004010
- **Lead sponsor:** Espad Pharmed
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07004010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07004010, "Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07004010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*